The best minds money can buy
MOST OF US place enormous faith in our universities. We trust that they are autonomous, independent institutions committed to education, scholarship, academic freedom and the production of knowledge free from the influence of special interest groups. Right?
Wrong. In the last 25 years, the United States has given birth to a market-model university, one where professors increasingly work "for hire." Just last week, the Wall Street Journal reported that a major academic study -- which found that antidepressants were safe and effective for pregnant women -- was tainted by undisclosed conflicts of interest.
Apparently, although the study itself was financed by the federal government, most of its 13 authors -- including many prominent academics -- also served as paid consultants to manufacturers of antidepressants. None of these financial ties were made public.
Reports like this have proliferated in the last decade. Today, it is common for professors to moonlight as consultants for drug firms. They receive generous stipends to join company advisory boards. For a nominal fee -- anywhere from $2,000 to $5,000 -- some professors will even agree to be named as authors on journal articles ghostwritten by the drug industry and published without disclosure of company involvement.
Editors at top medical journals have warned that such commercialism threatens to undermine the integrity of academic science, but the blurring of academia and commerce continues.
It's not just medical professors who have such conflicts. The new commercialism also involves law and business professors and academics in many scientific disciplines. It even affects administrators, such as Chancellor Marye Anne Fox of UC San Diego, who is a director at three corporations (two medical firms and a chemical company). In the last year alone they paid her cash and stock worth at least $339,260, according to the San Diego Union Tribune.
And the universities themselves, eager to share in the profits from research being done on campus, are getting in on the act. In recent years, changes in federal patent law have allowed universities to behave more like commercial enterprises. They now run their own patent offices and venture capital funds and industrial parks, and sometimes have equity interests in the companies that do the research, causing new institutional conflicts of interest.
